The agreement includes plans for distribution, technology transfer, local manufacturing, new pharmaceutical product development
The agency concluded that for people of all ages, IXCHI should be administered when there is a significant risk of chikungunya infection
Capricor’s BLA for Deramiocel received Priority Review in March 2025
New platform powered by Opentrons expands lab automation to accelerate scientific discovery
LEQSELVI now available for prescription in U.S. nationwide, offering a new option for eligible patients
Ukhade brings deep expertise in large-scale infrastructure planning, cross-functional leadership, and project innovation.
Spikevax is now approved for all individuals aged 6 months through 64 years at increased risk for COVID-19 disease
The company’s largest center for medical device applications, serving the entire Asian market
This collaboration marks a significant milestone for Abluva as the company aims to deliver value and innovative solutions in agentic AI security
Havix is a US based company engaged in the business of developing, manufacturing and supplying of various finished formulations
Subscribe To Our Newsletter & Stay Updated
